Apellis Pharmaceuticals, Inc.

MetLife Investment Management, LLC APLS

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

6,962

Value ($000)

175

Weight

0.0%

2018 Q3 - 2025 Q4 (30 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	175	0.0%	6,962	12/31/2025
2025 Q3	11/13/2025	156	0.0%	6,902	9/30/2025
2025 Q2	8/13/2025	116	0.0%	6,703	6/30/2025
2025 Q1	5/14/2025	144	0.0%	6,586	3/31/2025
2024 Q4	2/13/2025	205	0.0%	6,436	12/31/2024
2024 Q3	11/13/2024	190	0.0%	6,582	9/30/2024
2024 Q2	8/13/2024	257	0.0%	6,711	6/30/2024
2024 Q1	5/14/2024	361	0.0%	6,146	3/31/2024
2023 Q4	4/22/2024	367	0.0%	6,127	12/31/2023
2023 Q3	5/9/2024	233	0.0%	6,128	9/30/2023
2023 Q2	4/29/2024	558	0.0%	6,126	6/30/2023
2023 Q1	5/9/2024	3,237	0.0%	49,075	3/31/2023
2022 Q4	5/10/2024	2,568	0.0%	49,665	12/31/2022
2022 Q3	5/10/2024	3,392	0.0%	49,665	9/30/2022
2022 Q2	5/10/2024	2,136	0.0%	47,237	6/30/2022
2022 Q1	5/10/2024	2,098	0.0%	41,293	3/31/2022
2021 Q4	5/17/2024	1,169	0.0%	24,726	12/31/2021
2021 Q3	5/17/2024	798	0.0%	24,199	9/30/2021
2021 Q2	5/17/2024	1,529	0.0%	24,199	6/30/2021
2021 Q1	5/17/2024	1,038	0.0%	24,199	3/31/2021
2020 Q4	5/24/2024	1,384	0.0%	24,199	12/31/2020
2020 Q3	5/24/2024	807	0.0%	26,751	9/30/2020
2020 Q2	5/24/2024	874	0.0%	26,751	6/30/2020
2020 Q1	7/12/2023	680	0.0%	25,364	3/31/2020
2019 Q4	7/12/2023	683	0.0%	22,295	12/31/2019
2019 Q3	7/12/2023	537	0.0%	22,295	9/30/2019
2019 Q2	7/12/2023	565	0.0%	22,295	6/30/2019
2019 Q1	7/13/2023	337	0.0%	17,298	3/31/2019
2018 Q4	7/13/2023	228	0.0%	17,298	12/31/2018
2018 Q3	7/13/2023	308	0.0%	17,298	9/30/2018